Four research programs in the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI3) have received $72 million in federal funding from the Canada Biomedical Research Fund (CBRF) and Biomedical Research Infrastructure Fund (BRIF), bolstering the country’s biomanufacturing capacity and readiness to respond to emerging health threats.
Support for HI3 and the four funded research programs through the CBRF and BRIF is part of a larger investment in Canada’s Biomanufacturing and Life Sciences Strategy. The strategy aims to grow a strong, competitive domestic life sciences sector with cutting-edge biomanufacturing capabilities and to improve the country’s ability to respond to future health challenges.
HI3 – a coalition of 87 academic, hospital, research networks, industry, government, not-for-profit and community partners – was one of five national hubs established in March 2023 with CBRF funding.
Together, the four awarded programs will provide critical health intelligence data to guide the co-development of health threat surveillance platforms and next-generation precision interventions by the hub’s academic and industry partners, while building a highly skilled workforce to support Canada’s growing biomanufacturing and life sciences sector.
“Congratulations to HI3 and the collaborative teams behind these CBRF-funded programs. These four programs leverage the tremendous expertise of the University of Toronto's researchers and our partners in academia, hospitals, industry and other sectors to develop the talent, tools and data required to be at the forefront of emerging health threats,” said Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives.
“On behalf of the University of Toronto and HI3, I thank the government of Canada for its investment in building a strong domestic life sciences sector ready to take on the health challenges of today and tomorrow.”
One of the CBRF-funded programs is the Biomanufacturing Hub Network (BioHubNet), an immersive talent development program based at U of T and led by University Professor Molly Shoichet along with Darius Rackus, an assistant professor of chemistry and biology at Toronto Metropolitan University, and Gilbert Walker, a professor of chemistry at U of T.
More News
Image

Jeffrey Henderson Receives Prestigious Connaught Innovation Award
Award will support research to advance novel method of modifying cells for testing new gene therapies.
Read More
Image

Faces of PharmSci: Mahya Rezaeifarimani
Supervised by Prof. Shirley Wu, PhD student Mahya Rezaeifarimani is developing smart nanoparticles to help make radiation therapy work better for brain tumours by targeting low-oxygen areas that often make treatment less effective.
Read More
Image

Welcome Brandi Cambray - Assistant Professor, Teaching Stream
Assistant Professor Cambray will continue educating students on clinical decision making, preparing them to practice to the fullest of their professional scope.
Read More